Submitted by Anonymous (not verified) on 18 June 2025 - 10:40
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised